Related by context. All words. (Click for frequent words.) 68 subpopulation 67 subgroups 64 populations 60 genotypes 58 subtypes 58 missense mutations 58 clades 57 EGFR mutations 57 subgroup 57 haplotypes 56 genotypic 56 chromosomal regions 56 differentially expressed genes 56 genetic determinants 56 KRAS mutations 56 virologic responses 56 susceptibility genes 56 molecular subtypes 55 NNRTI resistance 55 isoforms 55 HER2 expression 55 tumor subtypes 55 species 55 prognostic factors 55 patient subpopulations 55 histological subtype 55 haplogroups 55 taxa 54 phenotypes 54 genetic polymorphisms 54 polymorphisms 54 orthologs 54 allele frequencies 54 phenotypic characteristics 54 prospectively defined 54 phenotype 54 liver transplant recipients 54 prognostic markers 54 isotypes 54 poor metabolizers 54 genes CYP#C# 54 serum concentrations 54 subspecies 54 K ras mutations 54 histologic subtypes 53 clade B 53 genotype 53 mRNA expression 53 demographic subgroups 53 heavily pretreated 53 splice variants 53 monophyletic 53 breast cancer subtypes 53 genetically distinct 53 ecoregions 53 seroprevalence 53 subsets 53 mutated K ras 53 histone modifications 53 genetic markers 53 myeloproliferative diseases 53 subtype 53 telomere lengths 53 HNSCC 53 HBV genotypes 53 PTPN# 53 histological subtypes 53 enterotypes 53 haplotype 53 morphological traits 53 seminomas 52 microRNA molecules 52 Subgroups 52 histologies 52 causal variants 52 phenotypically 52 colorectal tumors 52 metabolic parameters 52 KRAS mutation 52 PTEN gene 52 somatic mutations 52 homozygotes 52 distinct subtypes 52 allelic variation 52 TT genotype 52 histologic subtype 52 grizzly populations 52 serotypes 52 Bacteroides 52 loci 52 heritable traits 52 pharmacodynamic endpoints 52 susceptibility loci 52 subgroup analyzes 52 causative mutation 52 brucei 52 germline mutations 52 hepatocellular carcinomas 52 metabolic abnormalities 52 prognostic indicators 52 epitopes 52 alleles 52 SNP rs# [002] 52 functional polymorphism 52 HLA genes 52 KRAS status 51 rs# [004] 51 Baseline characteristics 51 methylation patterns 51 prognostically 51 K ras 51 tNOX 51 alanine aminotransferase ALT 51 homologs 51 molecularly defined 51 familial clustering 51 Tregs 51 subfamilies 51 MAPK pathway 51 epithelial tumors 51 baseline LDH 51 coinfection 51 genetic loci 51 adenocarcinomas 51 K ras mutation 51 Immune responses 51 prevalences 51 p# activation 51 pharmacodynamic parameters 51 subregions 51 hormone receptor status 51 IgA deficiency 51 prostate cancer CaP 51 FGFR2 51 Mus musculus 51 ABCB1 51 PBMCs 51 serum leptin 51 immunoreactivity 51 CNVs 51 critically endangered endangered 51 genetic variation 51 TGFBR1 * 6A 51 PNH patients 51 phylogenetically 51 gene polymorphisms 51 GSTM1 51 synthetic analogues 51 chromosomal alterations 51 VKORC1 51 EGFR mutation 51 Genotypes 51 ecotypes 51 lipid parameters 51 KRAS gene 51 epigenetic mechanisms 51 tumor histology 51 Alleles 51 IPAH 51 slow metabolizers 51 phylogeographic 51 CGG repeats 50 perilipin 50 constitutively expressed 50 pharmacologic intervention 50 MHC genes 50 phenotypic differences 50 MRSA isolates 50 Hsp# [001] 50 CCL#L# 50 plasma folate 50 capsular polysaccharide 50 H#K#me# 50 HPV subtypes 50 airway responsiveness 50 conserved sequences 50 ovarian carcinoma 50 T2DM 50 glucose intolerant 50 heterozygotes 50 microsatellite loci 50 ovariectomized 50 rs# [003] 50 mutations 50 comorbidities 50 EGFR expression 50 potent inhibitors 50 neutralizing antibody 50 mutant alleles 50 prognostic variables 50 morphologically distinct 50 miRNA expression 50 elevated triglyceride levels 50 carotid plaques 50 serum albumin 50 PGDH 50 gene variants 50 prion strains 50 gene expression profiles 50 plasma kallikrein 50 gene locus 50 primate species 50 normal karyotype 50 virological response 50 gene expression patterns 50 MYH9 50 multivariate analyzes 50 HIV HCV coinfected 50 BRAF mutation 50 cognitive domains 50 mRNA molecules 50 metapopulation 50 genetic variants 50 papillary renal cell carcinoma 50 transcriptomes 50 genetic variants associated 50 substrate specificity 50 lineages 50 lactobacilli 50 ZNF# 50 HBeAg positive 50 BDNF protein 50 chromosomal rearrangement 50 CCR7 50 heterozygous 50 gene loci 50 chronic HBV infection 50 genotypic resistance 50 ethnically diverse populations 50 genomic alterations 50 paralogs 50 bile acid metabolism 49 MYH9 gene 49 ecoregion 49 serum retinol 49 MGUS 49 covariates 49 mTOR inhibitors 49 hypertensives 49 serogroups 49 tumor xenograft models 49 genotyped 49 pressor response 49 subfamily 49 trans retinoic acid 49 hepatic fibrosis 49 reverse transcriptase inhibitors 49 genetic variability 49 metabolizing enzymes 49 dietary patterns 49 cardioprotective effect 49 hemoglobin concentration 49 hamartomas 49 gastric carcinogenesis 49 genes encoding 49 epitope 49 NPM1 mutations 49 activating mutations 49 interferon IFN 49 taxonomically 49 syngeneic 49 docetaxel pretreated 49 TOP2A 49 prion infection 49 chromosome #q# [001] 49 genetic variations 49 inflammatory biomarkers 49 breast carcinomas 49 IgG antibody 49 EBV infection 49 PON1 49 sporadic ALS 49 mitochondrial metabolism 49 HPV genotypes 49 etiologic factors 49 allelic 49 CpG 49 cyclin E 49 lung adenocarcinomas 49 NFKBIA 49 squamous histology 49 System IPSS 49 miR #a [001] 49 vertebrate species 49 antioxidant supplementation 49 avian species 49 evaluable 49 carotid plaque 49 microsatellite markers 49 prostate carcinoma 49 surrogate markers 49 ABCB1 gene 49 differentially expressed 49 estrogen receptor ER 49 fibrosis progression 49 TMPRSS2 ERG fusion 49 posttransplant 49 cynomolgus macaques 49 Epidemiologic studies 49 GBMs 49 transgene expression 49 MYCN amplification 49 cardiometabolic risk 49 protease inhibitor mutations 49 microdeletion 49 H5 viruses 49 salivary proteins 49 CD8 + 49 penetrance 49 serum lipid levels 49 IGFBP 49 antibody responses 49 nucleotide substitutions 49 Treg cell 49 serum phosphate levels 49 amnestic MCI 49 familial pancreatic cancer 49 CC genotype 49 phenotypic variation 49 APOE e4 49 UGT#B# 49 elevated triglycerides 49 UGT#A# * 49 dyslipidaemia 49 cellularity 49 ERK signaling 49 hippocampal neurons 49 lymphoma subtypes 49 FLT3 mutations 49 modifier genes 49 IFN alpha 49 beta globin gene 49 GSTT1 49 morphologically 49 N Myc 49 etiologic 49 adverse cytogenetics 49 narcolepsy cataplexy 49 randomized controlled trials RCTs 49 Peromyscus 49 metabolic enzymes 49 EGFR mutation status 49 vivax 49 HBeAg negative 49 circulating endothelial cells 49 ALDH2 48 predictive biomarker 48 bacterial genomes 48 K ras gene 48 #q#.# [002] 48 Plasmodium species 48 outbred 48 seronegative 48 membrane proximal 48 PITX2 48 serum PTH 48 chromosome #q#.# [001] 48 T#I [002] 48 autism susceptibility genes 48 DNA demethylation 48 RBC folate 48 transaminase levels 48 adjuvant therapy 48 lipid abnormalities 48 CHD mortality 48 caspofungin 48 uPAR 48 HLA DQ2 48 DLC1 48 Leydig cell 48 neurocognitive function 48 mosaicism 48 HCCs 48 prognostic biomarker 48 rs# [001] 48 heterozygote 48 clinically evaluable 48 monozygotic twins 48 heritable variation 48 cysteines 48 cytopathic 48 plasma adiponectin 48 gastric carcinoma 48 dietary intakes 48 S/GSK# 48 SNPs pronounced snips 48 estrogen receptor beta 48 bifidobacteria 48 metazoan 48 Estrogen Receptor 48 Subgroup analyzes 48 S. maltophilia 48 hepatoma 48 coding genes 48 hereditary predisposition 48 HCV infected 48 pathogenic mutations 48 inbred strains 48 Near Threatened 48 chromosome #q# [002] 48 microdeletions 48 reproductively isolated 48 metastatic prostate 48 CD8 responses 48 basal cell nevus syndrome 48 bladder carcinoma 48 circadian genes 48 LEAPS vaccines 48 SCr 48 immunocompetent 48 hemoglobin concentrations 48 Clusterin 48 nondiabetic 48 E#F# 48 #q# [001] 48 clinicopathological 48 IL#B 48 pneumococcal serotypes 48 IFN gamma 48 ribosomal proteins 48 efficacy evaluable 48 HIV tropism 48 covariate 48 underlying pathophysiology 48 IGF IR 48 initiating antiretroviral therapy 48 surrogate endpoint 48 renal tumors 48 Populations 48 phosphatases 48 MTHFR 48 plasma pharmacokinetics 48 SNPs 48 biomarkers 48 genetic alterations 48 Native Hawaiian Pacific Islander 48 lymphomas 48 phosphate S1P 48 ungulate species 48 QTLs 48 hyper IgE syndrome 48 socioeconomic status SES 48 breast carcinoma 48 HLA alleles 48 periodontal pathogens 48 gene polymorphism 48 refugia 48 micro RNAs 48 miRNA molecules 48 receptor subtypes 48 GBM tumors 48 seroprotection 48 infarcts 48 epistasis 48 SE alleles 48 prostate cancer PCa 48 differentially regulated 48 plasma glucose concentration 48 seropositivity 48 colorectal neoplasia 48 cell lymphomas 48 serum vitamin D 48 del 5q MDS 48 nanomolar 48 BMPR2 48 virulence genes 48 null responder 48 colonic mucosa 48 virologic failure 48 BRCA mutations 48 kidney transplant recipients 48 rhGH 48 peptide antigens 48 pilocytic astrocytomas 48 HCV genotype 48 genetic relatedness 48 Alu elements 48 GPx 48 cardiac troponin T 48 distinct lineages 48 antitumor efficacy 48 pharmacological approaches 48 phenotypic traits 48 gene rearrangements 48 mammalian species 48 hypermethylation 48 BARD1 48 HMGA1 48 ncRNAs 48 serum selenium 48 HLA DR 48 CYP#C# [002] 48 heterozygosity 48 microRNA expression 48 IgE antibody 48 metaplasia 48 C. jejuni 48 sialic acids 48 hydroxyvitamin D levels 48 confounders 48 multivariate Cox 48 coding sequences 48 mitochondrial genomes 48 univariate analyzes 48 FGFs 48 CLA supplementation 48 allele 48 castrate resistant 48 nucleotide sequence 48 HbF 48 BCR ABL mutations 48 tertiles 48 prespecified 48 differential gene expression 48 BRCA1 mutations 48 IgG4 48 pleiotropic effects 48 DRB1 * 48 hypermethylated 48 gambiae 48 causal pathways 48 vitellogenin 48 mutational status 48 pharmacological interventions 48 intestinal microflora 48 hematopoietic cancers 48 baseline CD4 48 subcellular compartments 48 Non Hodgkin lymphomas 48 KIT mutations 48 mutated KRAS gene 48 CagA 48 sequence homology 48 oligodendroglioma 48 socioeconomically disadvantaged 48 Genetic variations 48 nanomolar potency 48 triacylglycerol 47 signal transduction pathways 47 karyotype 47 ascending doses 47 biochemical abnormalities 47 Prochlorococcus 47 tumor biopsies 47 HCV replicon 47 behavioral disinhibition 47 cystatin C 47 comorbid conditions 47 microarray experiments 47 confounding variables 47 deleterious mutations 47 vitamin D receptors 47 indel 47 biologic pathways 47 HLA DR4 47 phylogenies 47 cellular pathways 47 CD# expression [002] 47 karyotypes 47 Genetic variation 47 progesterone receptor PR 47 adenocarcinoma histology 47 coexpression 47 folate concentrations 47 IGFBP 3 47 cytogenetic 47 quantitative trait loci 47 CYP#D# gene 47 TCF#L# 47 serine threonine kinases 47 HSCT 47 androgen receptor AR 47 osteopenic 47 EGFR tyrosine kinase inhibitors 47 isotype 47 APOE genotype 47 adiponectin concentrations 47 antibody titers 47 bilaterians 47 carcinoids 47 monogenic 47 HCV genotypes 47 #q# deletion 47 amino acid residues 47 atypical neuroleptics 47 SMAD4 47 baseline HbA1c 47 #S rRNA gene 47 HER2 receptor 47 extracellular domain 47 V#F mutation 47 MMSE scores 47 cognitively intact 47 metabolomic profiles 47 CSF biomarkers 47 translocations 47 pCR 47 ConclusionThis 47 homozygosity 47 mesotheliomas 47 serum calcium 47 mutant strains 47 epithelia 47 protein kinases 47 predisposing factors 47 haematopoietic 47 immunofluorescence microscopy 47 phylogenetic analyzes 47 urothelial carcinoma 47 A1c levels 47 seabird species 47 pharmacokinetic parameters 47 immunohistochemical staining 47 resistant isolates 47 sage grouse populations 47 siRNAs targeting 47 dosing regimens 47 albumin excretion 47 molecular pathways 47 Data Deficient 47 genetic locus 47 yellow legged frog 47 morphologic 47 histologically confirmed 47 DNA methylation patterns 47 mammary stem cells 47 wolverine populations 47 ependymomas 47 aT cell 47 ALK mutations 47 PI3K signaling 47 stratifying patients 47 Orcinus orca 47 hepatitis C genotype 47 sCJD 47 ascertainment bias 47 T1DM 47 etiologies 47 Kaplan Meier analysis 47 trimer 47 lipid lowering agents 47 beluga populations 47 nicotinic receptor 47 spontaneous mutations 47 elevated LDH 47 SIV infection 47 CYP#D# genotype 47 serum BDNF 47 sarcomatoid 47 developmental trajectories 47 randomized trials 47 p# biomarker 47 HDL cholesterol triglycerides 47 allele frequency 47 N. gonorrhoeae 47 HLA DRB1 * 47 Jhdm2a 47 PI3K pathway 47 juvenile idiopathic arthritis JIA 47 genetic lineages 47 birds amphibians reptiles 47 miRNA genes 47 fasting glucose levels 47 #p# [001] 47 clefting 47 gastric cancers 47 CYP#C# [001] 47 Yellowstone ecosystem 47 dosage regimens 47 RASSF1A 47 plasma lipid 47 EBNA1 47 adjuvant therapies 47 secondary efficacy endpoints 47 GABRA2 47 epigenetically 47 distantly related species 47 northern spotted owls 47 evolutionarily conserved 47 dose regimens 47 ANCOVA 47 homodimers 47 genomically 47 fig. S# 47 BRCA mutation carriers 47 genetic ancestry 47 polymorphism 47 hemoglobins 47 apolipoprotein B 47 undetectable HBV DNA 47 HLA B# 47 lipid profiles 47 Th1 47 choline intake 47 murrelets 47 methylated genes 47 superinfection 47 serum HBV DNA 47 splenectomized patients 47 tau protein tangles 47 KLF4 47 deleterious mutation 47 comorbid illnesses 47 globin genes 47 Recurrence Score 47 neurocognitive impairment 47 idiopathic myelofibrosis 47 H. pylori infection 47 SSc 47 Vps# 47 immunologically 47 HepG2 cells 47 chlamydial infection 47 non squamous histology 47 5 HTTLPR 47 hsCRP levels 47 Sprague Dawley rats 47 randomized controlled trials 47 blood glucose concentrations 47 posaconazole 47 unmethylated 47 PTP1B 47 phenotypic 47 antibody titer 47 pretreatment serum 47 chromosome aberrations 47 pseudogene 47 Resident killer whales 47 paricalcitol 47 lung carcinomas 47 MetS 47 methyltransferases 47 sociodemographic factors 47 serotonin receptor 47 Snake River sockeye 47 commensal bacteria 47 gut microbes 47 glycoproteins 47 fluconazole resistant 47 fluoroquinolone resistance 47 mitochondrial gene 47 C#BL 6 mice 47 normotensive 47 cathepsins 47 protein tyrosine phosphatase 47 GRK5 47 serous ovarian cancer 47 alkaline phosphatase 47 promoter methylation 47 genetic diversity 47 neurodevelopmental disorders 47 anaerobes 47 autoantibodies 47 NAFLD 47 familial predisposition 47 generalisable 47 molecular biomarkers 47 prenatal exposures 47 prognostic factor 47 dengue viruses 47 drug metabolizing enzymes 47 phenotypic expression 47 hyperhomocysteinemia 47 IgG1 46 hemoglobin A1c levels 46 non coding RNA 46 subclinical atherosclerosis 46 myopathies 46 innate immune responses 46 CORE OM 46 microsatellite instability 46 gene duplications 46 K#R [002] 46 MTHFR gene 46 immunopathology 46 proteomes 46 metastatic lesion 46 IKZF1 46 neoplastic lesions 46 C. albicans 46 phylogenetic relationships 46 kidney allograft 46 polymicrobial 46 molecular abnormalities 46 FLT3 46 surrogate marker 46 IL 1β 46 Indians Alaska Natives 46 genes predisposing 46 estrogen receptors 46 transthyretin 46 nonresponders 46 neutrophil counts 46 serum lipid 46 ovarian hormones 46 sexually dimorphic 46 kaempferol 46 S#A# [002] 46 micrometastases 46 physiologic parameters 46 immunostaining 46 mITT 46 exomes 46 terrestrial vertebrates 46 biochemical marker 46 antithrombotic agents 46 TACI mutations 46 NAbs 46 gray wolf populations 46 activin 46 BRCA2 mutation 46 granulocyte 46 #p#.# [001] 46 aminotransferase levels 46 gene mutations 46 cTnT 46 renal cell carcinomas 46 cardioprotective effects 46 observational cohort study 46 cytochrome b 46 CD3 + 46 CsA 46 HBV genotype 46 gonadal hormones 46 thiopurine 46 G allele 46 chemosensitivity 46 #q#.# [001] 46 carnivore species 46 lymphoid tumors 46 mutant BRAF 46 repeat allele 46 recombinants 46 clusterin 46 introgression 46 unmeasured confounding 46 Cetomimidae 46 Sei whales 46 EGFRvIII 46 mCRC patients 46 oral antidiabetic agents 46 CD4 + CD8 + 46 squamous cell lung cancer 46 viremia 46 PTEN mutations 46 Enterobacteriaceae 46 μmol L 46 chromosome #p#.# 46 VEGF receptors 46 granulocytes 46 extramedullary 46 recombination hotspots 46 aminotransferases 46 chromosome #p# [001] 46 AI AN 46 CCyR 46 dizygotic twins 46 pDCs 46 atherogenic dyslipidemia 46 phyla 46 HIV seropositive patient 46 peripheral blood mononuclear 46 BALB c mice 46 MLH1 46 fig. S1 46 CD# + [002] 46 obstructive coronary artery 46 orthologous genes 46 NOD mice 46 LDL cholesterol concentrations 46 serum markers 46 observational cohort 46 EphA2 46 Wwox 46 airway hyperresponsiveness 46 atypical hyperplasia 46 immunodeficient 46 S. aureus isolates 46 serum biomarkers 46 apoE4 46 impaired glucose metabolism 46 kinase inhibition 46 mtDNA sequences 46 herpesviruses 46 intracellular compartments 46 de novo mutations 46 methylation markers 46 myeloid 46 FDG PET 46 motor neuron degeneration 46 tigecycline 46 oncogenic HPV types 46 Acropora 46 decompensated liver disease 46 amino acid sequence 46 telomere length 46 cervical lymph nodes 46 NRTIs 46 epigenetic alterations 46 single nucleotide polymorphism 46 mtDNA mutations 46 imprinted genes 46 prognostic marker 46 lymphocytic 46 chromosomal aberrations 46 nonischemic 46 HbA 1c 46 clinicopathologic 46 metastatic lymph nodes 46 #S rRNA 46 polyp recurrence 46 C1q 46 osteosarcomas 46 outgroups 46 anterior pituitary 46 Notch receptor 46 downstream effectors 46 BCR ABL1 46 sociodemographic 46 immune dysregulation 46 hypercoagulable 46 dopamine transporter gene 46 Proteobacteria 46 4CMenB 46 gastric adenocarcinoma 46 NEDD9 46 abnormal lipid 46 p# mutation 46 humoral responses 46 anti JCV antibodies 46 ciliates 46 p# mutations 46 Longitudinal studies 46 clinically meaningful differences 46 serologically 46 genetic polymorphism 46 T. gondii 46 serum IgE 46 periprocedural MI 46 parasitaemia 46 Hp2 2 46 blastomeres 46 serogroup 46 perfusion abnormalities 46 brain lesions 46 xenograft models 46 immunized mice 46 complete cytogenetic response 46 pulmonary metastases 46 genotype 1a 46 viral isolates 46 nondiabetic patients 46 SNCA 46 residual confounding 46 serologic 46 supratentorial 46 HRQL 46 hypercholesterolemia 46 antihypertensive drugs 46 HSPCs 46 monocyte 46 gametocytes 46 carcinoid 46 CDKN2A 46 nonpregnant women 46 HBeAg 46 MIF gene 46 essential thrombocythemia 46 CD4 ^ sup 46 chlorthalidone 46 lymphocyte activation 46 sustained virological response 46 protein tyrosine phosphatases 46 lymphoblastoid cell lines 46 ASD prevalence 46 poorer prognosis 46 Ki# 46 mRNA transcripts 46 socioeconomic status 46 epigenetic changes 46 proteins encoded 46 Cytogenetic 46 cAMP signaling 46 codons 46 LTBI 46 lymphocyte counts 46 GISTs 46 prognostic significance 46 cells hESCs 46 APOE4 46 intergenic regions 46 SLNB 46 serum GGT 46 HDL2 46 nonmetastatic 46 APOL1 46 conspecifics 46 candidemia 46 faunas